Cochrane  is an international, independent, not-for-profit organization of over 30,000 contributors from more than 120 countries, dedicated to making up-to-date, accurate information about the effects of health care readily available worldwide. Our contributors work together to produce systematic reviews of healthcare interventions, known as Cochrane Reviews, which are published online in The Cochrane Library. Cochrane Reviews are intended to help providers, practitioners and patients make informed decisions about health care, and are the most comprehensive, reliable and relevant source of evidence on which to base these decisions.

The Sexually Transmitted Infections(STI) group is part of the School of Medicine of the National University of Colombia. The STICR counts with several international collaborators who want to develop the best systematic reviews of prevention, diagnosis and treatment of sexually transmitted infections and genital tract infections. The STI group has been re-registered in March 2012. We thank the Cochrane Collaboration Steering Group and the Cochrane Monitoring and Registration Committee for their support during the approval process.

In October 2011, at the Madrid Cochrane Colloquium, a re-registration meeting was held and a new submission made to The Cochrane Collaboration for re-registration initially as a Satellite Group of the Cochrane Menstrual Disorders and Subfertility Group, Auckland, New Zealand. At the time, it was proposed that the title of the group be changed from Sexually Transmitted Diseases Cochrane Group (STD) to Sexually Transmitted Infections Cochrane Group (STICR).

The Group initially began in 1997 under the editorship of Dr George Schmid at the Centers for Disease Control and Prevention (CDC) in the United States. It then moved to the Cochrane HIV/AIDs Group. From 2006, it was hosted in Porto Alegre, Brazil from 2006, as a Satellite of the Cochrane HIV/AIDS Group (2006-2008), but closed in 2009 due to insufficient funding. From 2009 to 2011 when no STD Group was registered, the Group's reviews and protocols (either published or in the editorial process), and registered titles were re-distributed among the Cochrane HIV/AIDS Group, Cochrane Infectious Diseases Group, the Cochrane Menstrual Disorders and Subfertility Group and the Cochrane Editorial Unit.